3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
3
Terminated
2
Active not recruiting
2
Withdrawn
1
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia, Myeloid, Acute
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Recurrence
13
Multiple Myeloma
12
Lymphoma, B-Cell
12
Lymphoma, Non-Hodgkin
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Ovarian Neoplasms
7
Lymphoma
7
Burkitt Lymphoma
7
Melanoma
5
Lymphoma, Mantle-Cell
5
Hematologic Neoplasms
5
Nasopharyngeal Carcinoma
4
Myelodysplastic Syndromes
4
Lymphoma, T-Cell
4
Leukemia
3
Graft vs Host Disease
3
Uterine Cervical Neoplasms
2
Sarcoma, Synovial
2
Neuroblastoma
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Leukemia, T-Cell
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Glioblastoma
2
Interventions
Docetaxel
21
Radiosurgery
20
Radiotherapy
17
Androgen Antagonists
14
Leuprolide
12
Goserelin
12
bicalutamide
11
Prednisone
9
Gonadotropin-Releasing Hormone
9
Abiraterone Acetate
9
enzalutamide
8
Surveys and Questionnaires
8
Radiotherapy, Intensity-Modulated
8
Brachytherapy
8
Blood Specimen Collection
8
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
7
Triptorelin Pamoate
7
Multiparametric Magnetic Resonance Imaging
7
abiraterone
5
pembrolizumab
4
cabazitaxel
4
Standard of Care
4
Positron Emission Tomography Computed Tomography
4
Metformin
4
Heavy Ion Radiotherapy
4
Flutamide
4
Exercise
4
Estramustine
4
luprolide acetate gel depot
3
darolutamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Prostatic Neoplasms
×
fludarabine
×
Clear all
NCT00625430
2011-07-11
FP253-GDEPT
Biotech Equity Partners Pty Ltd
Phase 1
Unknown
18 enrolled